Clinical Trials Browser

Phase 2/3 × Esophageal Squamous Cell Carcinoma × Fluorouracil × Clear all

NCT05213312 2022-06-15

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Phase 2/3 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00861094 2015-12-18

Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer

Phase 2/3 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms